Caixin
Caixin Global – Latest China News & Headlines

Home >

TRENDING
Tech Brief (Oct. 24): China Vows to Accelerate Tech Self-Reliance
Tech Brief (Oct. 23): China Cracks Down on Smart Devices Over Data Violations
LATEST
Tech Brief (Oct. 24): China Vows to Accelerate Tech Self-Reliance
Tech Brief (Oct. 23): China Cracks Down on Smart Devices Over Data Violations
Chinese Firms Urged to Fortify Online Brands as Cybersquatting Costs Mount
Tech Brief (Oct. 16): China’s Tech Minister Meets With Apple CEO
China Debuts Ultrafast Oscilloscope in Drive to Break Tech Barriers
Tech Brief (Oct. 15): Google to Invest $15 Billion in India for AI Hub
Tech Brief (Oct. 13): Wingtech Temporarily Loses Control of Dutch Chipmaker Nexperia
Tech Brief (Oct. 10): China’s AI Server Market Doubles
Tech Brief (Oct. 9): SoftBank to Acquire ABB’s Robotics Business
Tech Brief (Sept. 30): U.S. Widens Export Blacklist
U.S. Tightens Export Controls to Cover Subsidiaries of Blacklisted Firms
DeepSeek Unveils New Model With Sparse Attention, Slashes API Costs
Tech Brief (Sept. 29): Meituan’s Food-Delivery Platform Keeta Launches in Dubai
Chinese Chipmaker Moore Threads Gets Fast Track Approval to $1.1 Billion IPO
Chinese Drone Maker XAG Files for Hong Kong IPO After First Annual Profit
GPT Weekly: Nvidia to Invest $100 Billion in OpenAI
Tech Brief (Sept. 26): Trump Approves TikTok Deal
Xiaomi Ups the Stakes in Premium Market With iPhone-Style 17 Series
Yangtze Memory’s Parent Restructures to Pave Way for IPO Amid Sanctions Pressures
Tech Brief (Sept. 25): Alibaba Launches AI Models

By Charlotte Yang / Dec 11, 2018 07:10 PM / Economy

Photo: VCG

Photo: VCG

Changsheng Bio-Technology, which in a high-profile scandal earlier this year was revealed to have fabricated data on its vaccines for infants, has received an advance notification of mandatory delisting from the Shenzhen Stock Exchange.

The exchange described the vaccine-maker's illegal activities as “seriously damaging to national interests and public interests.”

In a separate announcement, the company said the China Securities Regulatory Commission fined 17 related personnel for market violations, banned four from entering China’s stock markets for life, and three from entering the market for five years.

Related: Data-Faking Vaccine Firm to Be Kicked Off Stock Exchange Under New Rules


Share this article
Open WeChat and scan the QR code